Clinical investigation of the changes in endocrinological and metabolic parameters on patients with adult growth hormone deficiency between daily and weekly growth hormone replacement therapy.

Clinical investigation of the changes in endocrinological and metabolic parameters on patients with adult growth hormone deficiency between daily and weekly growth hormone replacement therapy. - Investigation of the changes in patients with adult growth hormone deficiency between daily and weekly growth hormone replacement therapy.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049954

Enrollment

Registered

2023-01-04

Start date

2022-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult growth hormone deficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals with aGHD who had received daily GH replacement therapy and switched from daily GH replacement therapy to weekly GH replacement therapy between January 2022 and June 2022.

Exclusion criteria

Exclusion criteria: Individuals with aGHD who had not received daily GH replacement therapy, individuals whose treatments except GH replacement therapy have changed in the period, and individuals whose IGF1 changed over 1SD.

Design outcomes

Primary

Measure	Time frame
Changes in body mass index	—

Secondary

Measure	Time frame
Changes in metabolic and endocrinological parameters	—

Countries

Japan

Contacts

Public ContactKunihisa Kobayashi

Fukuoka University Chikushi Hospital Department of endocrinology and diabetes mellitus

nihisak@fukuoka-u.ac.jp+81929211011

Outcome results